Size of the ablation technology market with a value of US$ 18,090 million to

Pune, August 30, 2022 (GLOBE NEWSWIRE) — According to the latest report published by Growth Reports Plus, the Global ablation technology market the clock is expected US$18.09 billion by 2030 and grow at a CAGR of 8.9% during the forecast period. Due to the increasing prevalence of cardiovascular diseases and the availability of technologically advanced products, coupled with the increasing demand for minimally invasive procedures. This exclusive information is published by Growth Plus Reports in its report entitled “Ablation Technological Market – Global outlook and forecast period 2022-2030”

Request a sample copy of the investigation report:

market indicators

The increasing prevalence of cancer and cardiovascular diseases (CVD) and the growing geriatric population are the key growth factors of the global ablation market. Advantages such as quick recovery, lower risk of infections compared to traditional surgery, shorter hospital stays, decreased discomfort, and smaller incisions have led to increased demand for minimally invasive or non-invasive procedures. The commercial introduction of new generation technologies is also paving the way for market growth. For example, in January 2021, Medtronic Inc. received FDA approval for the DiamondTempTM ablation catheter, for the treatment of abnormal heart rhythms. This device has an improved imaging system, is more portable, and has higher accuracy.

The global ablation technology market has been analyzed from four perspectives: product, application, end-user, and region.

extracts sof ‘Segmentation by product’

Based on product type, the global ablation technology market is categorized into:

  • Radio frequency
  • Cryoablation
  • To be
  • Ultrasound
  • Microwave
  • Electric
  • hydrothermal

The radiofrequency segment dominated the global market with the largest market share in 2021, followed by cryoablation. In recent years, there has been a growing trend in the use of radiofrequency ablation technology in the treatment of a large number of conditions, such as heart disease, cancer, chronic pain and eye diseases. In addition, cryoablation is used to treat a variety of conditions, including skin abnormalities, atypical moles, warts, warts, actinic keratosis (precancerous skin growths), arrhythmia (abnormal heart rate and rhythm), and cancerous tumors (such as skin, liver, kidney, bone, lung, prostate and breast).

Excerpts from ‘By Application segmentation’

On the basis of application, the global ablation technology market is segmented into:

  • cancer treatment
  • cardiovascular treatment
  • gynecological treatment
  • cosmetic surgery
  • pain management
  • ophthalmological
  • urological
  • Orthopedic
  • Others
See also  TECH TUESDAY: Bringing data, technology and trust to private markets

The cardiovascular segment dominated the market with the largest market share in 2021. Cancer treatment is another prominent application area for ablation technologies. According to the American Cancer Society, in 2021 there will be ~1.9 million new cancer cases in the US and 608.57 cancer deaths. Various solid tumors are increasingly being treated with ablation procedures, with proven efficacy and safety. Therefore, the demand for highly safe and efficient technology for cancer treatment and the growing awareness of ablation procedures are expected to drive the growth of the segment.

Get a custom report based on your requirements:

Excerpts from ‘Segmentation by region’

Based on region, the global ablation technology market has been segmented into:

  • North America
  • Europe
  • Pacific Asia
  • Rest of the world

North America dominated the global ablation technology market in 2021, followed by Europe. The Asia Pacific market is anticipated to grow at the fastest CAGR during the forecast period. North America’s large share of the global ablation technology market can be attributed to the high demand for noninvasive or minimally invasive procedures, as well as the increased prevalence of cancer and cardiovascular disease. There is a high level of awareness in the region about ablation technology, as well as the presence of a developed healthcare infrastructure, high healthcare spending, and rapid adoption of novel treatment methods. For example, in 2019, the US FDA approved Abbott Laboratories’ TactiCath contact force ablation catheter for the treatment of atrial fibrillation. While Asia Pacific’s growth can be attributed to the increasing prevalence of cardiovascular disease and cancer, government initiatives in the region are raising awareness of ablation techniques. The increase in the geriatric population in the region is also a key growth factor. According to the WHO, the proportion of people aged 60 years and over is estimated to have been 9.8% in 2017 in Southeast Asia and is expected to rise to 13.7% in 2030 and reach 20.3% in 2050.

Excerpts from ‘Competitive Landscape’

Some of the prominent players operating in the global ablation technology market are

  • medtronic plc
  • AngioDynamics Inc.
  • Abbott Laboratories Inc.
  • Boston Scientific Corporation
  • Johnson & Johnson (Ethicon Inc.)
  • CONMED Corporation
  • Bausch & Lomb Incorporated
  • Biotronik SE & Co. KG
  • AtriCure Inc
  • Varian Medical Systems
  • Olympus Corporation
  • Dornier MedTech
  • Among others
See also  Latest free Live Home 3D update now supports Apple's RoomPlan technology

Table of Contents:

    1. market ecosystem
    2. Timeline under consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Projected years: 2022 to 2030
    3. Currency used in the report
    1. Research focus
    2. Data collection methodology
    3. data sources
      1. secondary sources
      2. primary sources
    4. Market estimation approach
      1. Bottom up
      2. From top to bottom
    5. Market forecast model
    6. Limitations and assumptions
    1. Current market trend (COVID-19 outlook)
    2. Key players and competitive positioning (2021)
    1. drivers
    2. Restrictions/Challenges
    3. Opportunities
    1. Radio frequency
    2. Cryoablation
    3. To be
    4. Ultrasound
    5. Microwave
    6. Electric
    7. hydrothermal
    1. Cancer
    2. Cardiovascular
    3. Gynecological
    4. Cosmetic
    5. pain management
    6. ophthalmological
    7. urological
    8. Orthopedic
    9. Others
    1. hospitals
    2. Ambulatory Surgical Centers
    3. medicinal spas
    4. Others

OCD Continued…


  • Powered by complimentary analyst hours and expert interviews with every report
  • Comprehensive quantitative and qualitative insights at the segment and sub-segment level
  • Covid 19 impact trends and outlook
  • Granular insights at the global/regional/country level
  • Deep insights into market dynamics (drivers, constraints, opportunities) and the business environment
  • General coverage of the competitive landscape
  • win imperatives
  • Comprehensive coverage on ‘Strategic Developments’ recorded by major market players


  • Dealer Landscape Assessment
  • price intelligence
  • Evaluation of the customer base
  • Analysis of Investments and Initiatives
  • ‘Business profile’ of key players

Talk to our expert:

About us:

Growth Plus Reports is part of GRG Health, a global healthcare insights services company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus’ portfolio of services builds on our core capabilities of secondary and primary research, market modeling and forecasting, benchmarking, analysis and strategy formulation to help clients create scalable and innovative solutions that prepare them for growth. and future success.

We were awarded by the prestigious CEO Magazine as “The most innovative healthcare market research company in 2020.


Leave a Comment